These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39192007)

  • 1. Navigating the transition: a multidisciplinary approach to inflammatory bowel disease in children.
    Raffaele A; Ferlini CM; Fusi G; Lenti MV; Cereda E; Caimmi SME; Bertozzi M; Riccipetitoni G
    Pediatr Surg Int; 2024 Aug; 40(1):245. PubMed ID: 39192007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of multidisciplinary team care with abundant nurse staffing on patient-reported outcomes among patients with inflammatory bowel disease in clinical remission.
    Tanaka M; Kawakami A; Sakagami K; Terai T; Ito H
    Health Qual Life Outcomes; 2024 Jun; 22(1):44. PubMed ID: 38835030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Planned Transition of Adolescent Patients with Inflammatory Bowel Disease Results in Higher Remission Rates.
    Otto C; Tárnok A; Erős A; Szakács Z; Vincze Á; Farkas N; Sarlós P
    J Pediatr Nurs; 2019; 45():62-66. PubMed ID: 30745207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and therapeutic characterisation of a multicentre cohort of patients with inflammatory bowel disease in Colombia.
    Parra-Izquierdo V; Flórez Sarmiento C; Frías-Ordoñez JS; Vargas M; Kock J; Lozano Escobar N; Márquez JR
    Gastroenterol Hepatol; 2023 Oct; 46(8):585-593. PubMed ID: 36464080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN.
    Aloi M; Birimberg-Schwartz L; Buderus S; Hojsak I; Fell JM; Bronsky J; Veereman G; Koletzko S; Shaoul R; Miele E; Turner D; Russell RK
    Inflamm Bowel Dis; 2016 Jun; 22(6):1378-83. PubMed ID: 27135479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort.
    Lee WS; Ng RT; Chan KW; Lau YL
    World J Gastroenterol; 2016 Dec; 22(48):10653-10662. PubMed ID: 28082818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.
    Massuger W; Moore GTC; Andrews JM; Kilkenny MF; Reyneke M; Knowles S; Purcell L; Alex G; Buckton S; Page AT; Stocks N; Cameron D; Manglaviti F; Pavli P
    Intern Med J; 2019 Jul; 49(7):859-866. PubMed ID: 30525299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helminth therapy (worms) for induction of remission in inflammatory bowel disease.
    Garg SK; Croft AM; Bager P
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009400. PubMed ID: 24442917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
    Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
    Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and trend of pediatric inflammatory bowel disease: A two-decade experience from northern India.
    Mohan N; Deswal S; Bhardwaj A
    Indian J Gastroenterol; 2024 Feb; 43(1):208-214. PubMed ID: 37943479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition readiness in pediatric patients with inflammatory bowel disease: patient survey of self-management skills.
    Whitfield EP; Fredericks EM; Eder SJ; Shpeen BH; Adler J
    J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):36-41. PubMed ID: 25199036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition Readiness Not Associated With Measures of Health in Youth With IBD.
    Arvanitis M; Hart LC; DeWalt DA; Díaz-González de Ferris ME; Sawicki GS; Long MD; Martin CF; Kappelman MD
    Inflamm Bowel Dis; 2021 Jan; 27(1):49-57. PubMed ID: 32109284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.
    Ruuska T; Wewer V; Lindgren F; Malmborg P; Lindquist M; Marthinsen L; Browaldh L; Casswall T; Kalliomäki M; Grönlund J
    Inflamm Bowel Dis; 2009 Jul; 15(7):1049-54. PubMed ID: 19137602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN.
    Birimberg-Schwartz L; Zucker DM; Akriv A; Cucchiara S; Cameron FL; Wilson DC; Lazowska I; Yianni L; Paul SP; Romano C; Kolacek S; Buderus S; Pærregaard A; Russell RK; Escher JC; Turner D;
    J Crohns Colitis; 2017 Sep; 11(9):1078-1084. PubMed ID: 28430891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination biologic therapy in pediatric inflammatory bowel disease: Safety and efficacy over a minimum 12-month follow-up period.
    Wlazlo M; Meglicka M; Wiernicka A; Osiecki M; Matuszczyk M; Kierkus J
    J Pediatr Gastroenterol Nutr; 2024 Jul; 79(1):54-61. PubMed ID: 38477410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
    Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
    Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt.
    Esmat S; El Nady M; Elfekki M; Elsherif Y; Naga M
    World J Gastroenterol; 2014 Jan; 20(3):814-21. PubMed ID: 24574754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.